Jubilant Ingrevia Share Price in Focus; To Acquire 40% Stake in Zettaone Technologies

Jubilant Ingrevia Limited has entered into a binding term sheet with Zettaone Technologies India Private Limited for a 40% stake. The transaction is valued at approximately ₹189.2 crore and will be funded through cash.  

The company’s Board approved and announced the deal on August 18, 2026. 

Jubilant Enters EDMS 

The deal will take Jubilant Ingrevia into Electronics Development and Manufacturing Services, or EDMS.  

The company said it will use its existing manufacturing and customer capabilities from the CDMO business for work in electronics and semiconductors. 

Two-Part Completion 

The acquisition will be completed in two tranches. The first is expected by November 2026 and the second by September 2027.  

Jubilant Ingrevia said no government or regulatory approvals are required for the transaction. 

Zettaone’s Business 

Zettaone works in electronics design and manufacturing. Its work includes R&D, product design and prototyping, manufacturing, assembly and box build. Its business covers aerospace, defence, semiconductor, automotive, medical and industrial applications. 

Zettaone’s Turnover Rises 

Zettaone’s turnover stood at ₹98.1 crore in FY2025-26, up from ₹79.1 crore in FY2024-25. It was ₹51.1 crore in FY2023-24. The company was co-founded by Harikrishnan, Sureshkumar, Prabu, and Arunkumar and has been operating for about two decades. 

Jubilant Ingrevia’s Business 

Jubilant Ingrevia has more than 130 products and operates in specialty chemicals and CDMO. Its businesses serve pharmaceutical, nutrition, agrochemical, consumer, semiconductor, and industrial customers.  

The company has over 2,300 employees and 50-plus plants across 6 manufacturing facilities in India. 

Read More: BPCL Share Price in Focus; Plans to Raise Up to ₹5,000 Crore Through NCDs! 

Jubilant Ingrevia Share Price Performance  

As of August 19, 2026, 11:05 am, Jubilant Ingrevia share price was trading at ₹717.05, a 1.33% decrease from the previous closing price. 

Conclusion 

The transaction will give Jubilant Ingrevia a 40% holding in Zettaone for about ₹189.2 crore. The second part of the acquisition is to be completed by September 2027. 

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.   
 
Investments in the securities market are subject to market risks, read all the related documents carefully before investing.